Cargando…
Bcl-2-like protein-10 increases aggressive features of melanoma cells
AIM: B-cell lymphoma-2 (Bcl-2)-like protein-10 (Bcl2L10) is the less studied member of Bcl-2 family proteins, with the controversial role in different cancer histotypes. Very recently, Bcl2L10 expression in melanoma tumor specimens and its role in melanoma response to therapy have been demonstrated....
Autores principales: | Del Bufalo, Donatella, Di Martile, Marta, Valentini, Elisabetta, Manni, Isabella, Masi, Ilenia, D’Amore, Antonella, Filippini, Antonio, Nicoletti, Carmine, Zaccarini, Marco, Cota, Carlo, Castro, Maria Victoria, Quezada, María Josefina, Rosanò, Laura, Lopez-Bergami, Pablo, D’Aguanno, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400776/ https://www.ncbi.nlm.nih.gov/pubmed/36046354 http://dx.doi.org/10.37349/etat.2022.00068 |
Ejemplares similares
-
SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
por: Valentini, Elisabetta, et al.
Publicado: (2021) -
Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
por: D’Aguanno, Simona, et al.
Publicado: (2020) -
BCL-X(L) overexpression promotes tumor progression-associated properties
por: Trisciuoglio, Daniela, et al.
Publicado: (2017) -
Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models
por: Di Martile, Marta, et al.
Publicado: (2021) -
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
por: D’Aguanno, Simona, et al.
Publicado: (2018)